The crispr gene editing global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
CRISPR Gene Editing Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size – The CRISPR gene editing market size has grown exponentially in recent years. It will grow from $1.78 billion in 2023 to $2.26 billion in 2024 at a compound annual growth rate (CAGR) of 26.9%. The growth in the historic period can be attributed to increased demand for genome editing technologies, rise in government funding, increased cancer cases, increased prevalence of chronic diseases, increased awareness about CRISPR technology, rise healthcare infrastructure.
The CRISPR gene editing market size is expected to see exponential growth in the next few years. It will grow to $5.92 billion in 2028 at a compound annual growth rate (CAGR) of 27.2%. The growth in the forecast period can be attributed to increasing prevalence of genetic disorders, growing emphasis on precision medicine, rising investment in CRISPR research and development, increasing geriatric population, growing prominence for the gene therapy procedures. Major trends in the forecast period include advancements in gene editing technology, expansion in the number of research studies, drug discovery and development, innovation in delivery methods, adoption of CRISPR-edited agriculture.
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report
Scope Of CRISPR Gene Editing MarketThe Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
CRISPR Gene Editing Market Overview
Market Drivers -The increasing prevalence of genetic disorders is expected to propel the growth of the CRISPR gene editing market going forward. A genetic disorder is a health problem caused by genome abnormalities, which include mutations in a single gene (monogenic), multiple genes (polygenic), or chromosomal abnormalities. The prevalence of genetic disorders is increasing due to genetic mutations, aging populations, and consanguineous marriage. CRISPR gene editing significantly aids in managing genetic disorders by providing precise and targeted modifications to the DNA. Further, scientists use CRISPR to identify and correct specific mutations causing genetic disorders, restore normal function, and alleviate disease symptoms, as seen in conditions such as cystic fibrosis and sickle cell anemia. For instance, in April 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, about 6,000 babies born in the United States have Down syndrome each year, which occurs in about 1 in every 700 babies. Therefore, the increasing prevalence of genetic disorders is driving the growth of the CRISPR gene editing market.
Market Trends – Major companies operating in the CRISPR gene editing market are focused on developing innovative products, such as CRISPR gene editing tools, to provide researchers with reliable and efficient solutions, enabling rapid and simplified analysis of gene editing experiments. CRISPR gene editing tools are a solution for CRISPR genome editing experiments that will allow researchers to study edited genetic material with unprecedented speed and efficiency, determining how their interventions have altered the function of the DNA sequence in question. For instance, in June 2021, QIAGEN, a Germany-based provider of sample and assay technologies for molecular diagnostics, academic research, and pharmaceutical research, launched the QIAprep& and CRISPR Kit and CRISPR Q-Primer. These tools are designed to determine cells edited with CRISPR technologies, offering a sensitive, all-in-one solution for defining knock-outs and knock-ins produced during gene editing. The QIAprep&CRISPR Kit and CRISPR Q-Primer Solutions integrate liquid-based sample preparation with downstream PCR detection and Sanger sequencing, resulting in a seven-day reduction in experiment time compared to conventional approaches.
The CRISPR gene editing market covered in this report is segmented –
1) By Type: CRISPR-Associated Nuclease (Cas Nuclease), Guide Ribonucleic Acid (RNA), Deoxyribonucleic Acid (DNA) Ligase, Restriction Endonuclease, Other Types
2) By Services: Design Tools, Plasmid And Vector, CRISPR-Associated Protein 9 (Cas9) And Guide Ribonucleic Acid (g-RNA), Delivery System Products, Other Services
3) By Technology: CRISPR Or Cas9, Zinc Finger Nucleases, Other Technologies
4) By Application: Agricultural, Biomedical , Industrial, Genome Engineering, Disease Models, Functional Genomics, Other Applications
5) By End User: Academic Institutes And Research Centers, Biotechnology Companies, Contract Research Organizations (CROs), Pharmaceutical And Biopharmaceutical Companies
Get an inside scoop of the crispr gene editing market, Request now for Sample Report
https://www.thebusinessresearchcompany.com/sample.aspx?id=15549&type=smp
Regional Insights – North America was the largest region in the CRISPR gene editing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies – Major companies operating in the CRISPR gene editing market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., GenScript, Integrated DNA Technologies Inc., Takara Bio Inc., OriGene Technologies Inc., Intellia Therapeutics Inc., New England Biolabs, Synthego, Arbor Biotechnologies Inc., Rockland Immunochemicals Inc. , Cellectis, Editas Medicine, Caribou Biosciences Inc., System Biosciences LLC, Applied StemCell, Addgene, Mirus Bio LLC, Excision BioTherapeutics Inc., GeneCopoeia Inc., ToolGen Inc., Cellecta Inc., CRISPR Therapeutics, ERS Genomics Limited
Table of Contents
1. Executive Summary
2. CRISPR Gene Editing Market Characteristics
3. CRISPR Gene Editing Market Trends And Strategies
4. CRISPR Gene Editing Market – Macro Economic Scenario
5. Global CRISPR Gene Editing Market Size and Growth
….
32. Global CRISPR Gene Editing Market Competitive Benchmarking
33. Global CRISPR Gene Editing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The CRISPR Gene Editing Market
35. CRISPR Gene Editing Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model”
